Working... Menu

Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer (EECLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02729493
Recruitment Status : Recruiting
First Posted : April 6, 2016
Last Update Posted : March 15, 2017
Information provided by (Responsible Party):
Sinobioway Cell Therapy Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2019
  Estimated Study Completion Date : November 2019